logo

For the Inventor, By the Inventor

Seattle, WA, United States of America

Pathogenesis Corporation

Calculating rank
USPTO Granted Patents = 11

Trademarks = 1

Forward Citations = 323

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal William R Baker (5 out of 21 patents)

silverMedal Alan B Montgomery (3 out of 6 patents)

bronzeMedal Cai Shaopei (2 out of 2 patents)

4.  Eric L Keeler (2 out of 2 patents)

5.  Lester A Mitscher (2 out of 14 patents)

6.  Charles K Stover (2 out of 19 patents)

7.  Arnold L Smith (1 out of 5 patents)

8.  Gregory G Mahairas (1 out of 2 patents)

9.  Peter Bruce Challoner (1 out of 5 patents)

10.  James R Harness (1 out of 5 patents)

11.  Bonnie W Ramsey (1 out of 1 patent)

12.  Mark Jeffrey Hickey (1 out of 1 patent)

13.  Donald Robert VanDevanter (1 out of 1 patent)

14.  Jay David Parker (1 out of 1 patent)

15.  Kirsten Towne Smith (1 out of 1 patent)


11 patents:

1. 6087358 - Nitro-[2,1-b]imidazopyran compounds and antibacterial uses thereof (2000-07-11),
2. 6083922 - Method and a tobramycin aerosol formulation for treatment prevention and (2000-07-04),
3. 5767068 - Pure biologically active colistin, its components and a colistin (1998-06-16),
4. 5759780 - Methods for enriching target nucleic acid sequences (1998-06-02),
5. 5716584 - Device for the synthesis of compounds in an array (1998-02-10),
6. 5700683 - Virulence-attenuating genetic deletions deleted from mycobacterium BCG (1997-12-23),
7. 5679515 - Mycobacterial reporter strains and uses thereof (1997-10-21),
8. 5668127 - Nitroimidazole antibacterial compounds and methods of use thereof (1997-09-16),
9. 5508269 - Aminoglycoside formulation for aerosolization (1996-04-16),
10. 5441955 - Indolo[2,1-biquinazoline-6,12-dione antibacterial compounds and methods (1995-08-15),
11. 5399558 - Isoflavonoid antibacterial compounds, compositions and use (1995-03-21),
Company Overview
Pathogenesis Corporation, based in Seattle, WA, specializes in the development of innovative therapeutic solutions targeting infectious diseases. The company focuses on advanced research in microbiology and immunology, aiming to create effective treatments that address unmet medical needs. With a commitment to scientific excellence, Pathogenesis leverages cutting-edge technologies to enhance patient outcomes and contribute to the global fight against pathogens. Its work is pivotal in advancing healthcare solutions that improve quality of life.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

11 Patents

#183 in Seattle, WA

#630 in Washington

#27,540 in US

#51,831 in the World

Seattle, WA (US)
Seattle, WA, United States of America

Pathogenesis Corporation

Forward Citations = 323

16 inventors:

goldMedal William R Baker (5 out of 21 patents)

silverMedal Alan B Montgomery (3 out of 6 patents)

bronzeMedal Cai Shaopei (2 out of 2 patents)

4.  Eric L Keeler (2 out of 2 patents)

5.  Lester A Mitscher (2 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pathogenesis Corporation. Retrieved from https://idiyas.com/company/pathogenesis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…